Clinical Trial VICCHN0529
Title
Novel Protein Regulator of Tumor Suppressor ARF & NF-kB (NIH/2 R01 DEO13173-05) (deidentified)
Principal Investigator(s)
Details
- Protocol No. VICCHN0529
- Open Date: 05/10/2005
- Staging: NA
- Age Group: Adults
- Scope: Local
- Objective:
- Disease Sites: Head/Neck
- Therapies: Correlative
- Drugs: None Specified
- Participating Institutions: Vanderbilt University; Veterans Administration
- National Clinical Trial ID: NCT00896948
- Secondary Protocol No: Not Specified
Description
None Provided.
Eligibility
| Ages Eligible for Study: | N/A and older |
|---|---|
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
DISEASE CHARACTERISTICS:
• Head and neck cancer tumor cell line
PATIENT CHARACTERISTICS:
• Not specified
PRIOR CONCURRENT THERAPY:
• Not specified
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
